- Home
- HOTH vs ACON Comparison
HOTH vs ACON Comparison
Compare HOTH & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- ACON
- Stock Information
- Founded
- HOTH 2017
- ACON 2008
- Country
- HOTH United States
- ACON United States
- Employees
- HOTH N/A
- ACON N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- HOTH Health Care
- ACON Technology
- Exchange
- HOTH Nasdaq
- ACON Nasdaq
- Market Cap
- HOTH 8.3M
- ACON 7.1M
- IPO Year
- HOTH 2019
- ACON 2022
- Fundamental
- Price
- HOTH $0.98
- ACON $12.61
- Analyst Decision
- HOTH Strong Buy
- ACON Buy
- Analyst Count
- HOTH 4
- ACON 2
- Target Price
- HOTH $4.75
- ACON $481.00
- AVG Volume (30 Days)
- HOTH 623.8K
- ACON 370.3K
- Earning Date
- HOTH 05-13-2025
- ACON 05-14-2025
- Dividend Yield
- HOTH N/A
- ACON N/A
- EPS Growth
- HOTH N/A
- ACON N/A
- EPS
- HOTH N/A
- ACON N/A
- Revenue
- HOTH N/A
- ACON $49,289.00
- Revenue This Year
- HOTH N/A
- ACON N/A
- Revenue Next Year
- HOTH N/A
- ACON $186.36
- P/E Ratio
- HOTH N/A
- ACON N/A
- Revenue Growth
- HOTH N/A
- ACON N/A
- 52 Week Low
- HOTH $0.58
- ACON $9.75
- 52 Week High
- HOTH $3.80
- ACON $6,241.05
- Technical
- Relative Strength Index (RSI)
- HOTH 42.23
- ACON 33.96
- Support Level
- HOTH $1.01
- ACON $9.75
- Resistance Level
- HOTH $1.19
- ACON $15.08
- Average True Range (ATR)
- HOTH 0.07
- ACON 3.14
- MACD
- HOTH -0.01
- ACON 12.50
- Stochastic Oscillator
- HOTH 23.82
- ACON 13.43
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.